drugset / Trial / NCT01126229

Resveratrol for Improved Performance in the Elderly

NCT01126229

Phase 1 Completed 32 enrolled University of Florida
RandomizedParallel-groupQuadruple-blind

Summary

The investigators aim to conduct a randomized placebo controlled pilot study to determine whether resveratrol, a dietary ingredient, supplementation is safe and improves memory and physical performance in older adults. Loss in memory and physical performance is a frequent complaint in older adults and a growing public health issue. Additionally, later adulthood is associated with a normative decline in both working and primary memory as well as domains including attention, speed of processing and executive function. Resveratrol is safely tolerated in pre-clinical models and in dose-escalation human studies. It also has demonstrated beneficial effects on memory and performance in pre-clinical models. Therefore, this study will take the next step in understanding the longer-term safety (3 months) and efficacy of resveratrol supplementation on age-related health conditions.

Timeline

Start
2009-11
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Resveratrol Small molecule 300 mg Oral
Subject Resveratrol Small molecule 1000 mg Oral

Indications

No indication recorded.